Delivery Order SPE2DB24D3014-SPE2DB25FKSUC

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,533.72 firm fixed-price delivery order is for the provision of 4,565,029,546 units of METOPROLOL SUCC ER 25 MG TAB with a completion date of July 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,757.17, is a Delivery Order for the supply of 4567409176 - METOPROLOL SUCC ER 100 MG TAB 1000S. The contract has an ultimate completion date of February 28, 2025 and is a Firm Fixed Price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,969.72, is for the delivery of 4565243413 METOPROLOL SUCC ER 50 MG TAB 1000S, a cardiovascular medication, with a completion date of July 25, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 1,000 units of the medication Metoprolol Succinate Extended-Release 25 mg tablets, a cardiovascular drug. The award has a ceiling value of $1,499.59 and a completion date of September 20, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,482,541 units of Metoprolol Succinate Extended-Release 100 mg tablets. The $1,037.98 fixed-price contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,743.51 firm fixed-price delivery order is for the supply of 4,559,461,647 units of Metoprolol Succinate ER 25 mg tablets. The award has an ultimate completion date of December 29, 2022 and was made on December 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Metoprolol Succinate Extended-Release 100 mg Tablets. The award, with a ceiling value of $1,947.80, was made by the Defense Logistics Agency (DLA) Troop Support Medical on June 18, 2024, with a completion date of June 20, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. In addition to this specific award, Amerisourcebergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,558,059,646 units of the drug Metoprolol Succinate Extended-Release 25 mg tablets. The contract has a firm fixed price of $4,088.37 and an ultimate completion date of August 11, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKSUC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,184.14, is for the delivery of 4567409375 METOPROLOL SUCC ER 25 MG TAB 1000S, with a period of performance through February 28, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:18 AM